Literature DB >> 3815344

Natural killer cells in the host response to melanoma.

M J Kornstein, R Stewart, D E Elder.   

Abstract

Using an immunoperoxidase technique, we have investigated natural killer (NK) cells in the host response to malignant melanomas and melanocytic nevi in frozen sections. Eight primary melanomas, 12 metastatic melanomas, and 31 dysplastic nevi were studied. NK cells were identified phenotypically using an antibody, B73.1, against an Fc receptor present only on NK cells and neutrophils. Rare NK cells were identified in three of 31 dysplastic nevi and in one of eight melanomas. In contrast, significant numbers of NK cells were identified in ten of 12 metastases.

Entities:  

Mesh:

Year:  1987        PMID: 3815344

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  Cultured brain endothelium inhibits the cytocidal action of natural killer cells on glioma.

Authors:  J M Rozental; G M Kaminska; M J Kaminski
Journal:  J Neurooncol       Date:  1989-05       Impact factor: 4.130

2.  NK cells sense tumors, course of disease and treatments: Consequences for NK-based therapies.

Authors:  Giulia Fregni; Aurélie Perier; Marie-Françoise Avril; Anne Caignard
Journal:  Oncoimmunology       Date:  2012-01-01       Impact factor: 8.110

3.  Phenotypic and functional characteristics of blood natural killer cells from melanoma patients at different clinical stages.

Authors:  Giulia Fregni; Meriem Messaoudene; Emmanuelle Fourmentraux-Neves; Sarra Mazouz-Dorval; Johan Chanal; Eve Maubec; Eduardo Marinho; Isabelle Scheer-Senyarich; Isabelle Cremer; Marie-Françoise Avril; Anne Caignard
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

4.  Patient's Natural Killer Cells in the Era of Targeted Therapies: Role for Tumor Killers.

Authors:  Meriem Messaoudene; Alexandra Frazao; Pierre Jean Gavlovsky; Antoine Toubert; Nicolas Dulphy; Anne Caignard
Journal:  Front Immunol       Date:  2017-06-12       Impact factor: 7.561

5.  Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor.

Authors:  K Itoh; C D Platsoucas; C M Balch
Journal:  J Exp Med       Date:  1988-10-01       Impact factor: 14.307

6.  BRAF inhibitor resistance of melanoma cells triggers increased susceptibility to natural killer cell-mediated lysis.

Authors:  Alexandra Frazao; Louise Rethacker; Géraldine Jeudy; Marina Colombo; Eric Pasmant; Marie-Françoise Avril; Antoine Toubert; Helene Moins-Teisserenc; Marie Roelens; Sophie Dalac; Eve Maubec; Anne Caignard
Journal:  J Immunother Cancer       Date:  2020-09       Impact factor: 13.751

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.